Andrea Gambotto Quotations

We hope this will happen soon, because it's not nice to wait. It's a little frustrating that nobody wants to spend the money, that nobody wants this to become real.

In humans, the H5N1 bird flu takes about two weeks to kill, so there is time for T cells to come out and give protection.

It takes a little over a month for us to develop a recombinant vector vaccine compared to a minimum of several months via traditional methods. This capacity will be particularly invaluable if the virus begins to mutate rapidly, a phenomenon that often limits the ability of traditional vaccines to contain outbreaks of mutant strains.

We have the technique to go from an email to a virus.

And if avian flu develops into a pandemic human strain - as many experts fear it may - the vaccine might complement traditional vaccines and be used to protect people.

The results of this animal trial are very promising, not only because our vaccine completely protected animals that otherwise would have died, but also because we found that one form of the vaccine stimulates several lines of immunity against H5N1.

Eventually we will need to partner with a company for large-scale production of vaccine.

That means there is a lot of chance of getting cross-reactivity.

Some people would say you were crazy if you were to say you were making a vaccine as a way to make money for the university. It could happen.

This is a very potent vaccine. The results of this animal trial are very promising.